Article
Evaluation of the cobas® GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures.
PloS one - 1 Jan 2018
Némoz Benjamin, Roger Léa, Leroy Vincent, Poveda Jean-Dominique, Morand Patrice, Larrat Sylvie
Abstract excerpt
Direct-acting antiviral (DAA) drug performances depend on the viral genotype. So international recommendations give typing of the virus a prerequisite for treatment choice and patient management. Commercially available HCV genotyping kits are scarce and this analysis is often in-house using tedious PCRs and Sanger sequencing, leading to a lack of standardization. A newly commercialized HCV genotyping assay based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
